Efficacy and safety of therapeutic alpha-1-microglobulin RMC-035 in reducing kidney injury after cardiac surgery: a multicentre, randomised, double-blind, parallel group, phase 2a trial

Authors

Institutions

Publication Details

Journal
EClinicalMedicine
Published
2024-09-16
DOI
https://doi.org/10.1016/j.eclinm.2024.102830
Citations
6
Primary Topic
Acute Kidney Injury Research
Type
article
Field-Weighted Citation Impact
2.04

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and safety of therapeutic alpha-1-microglobulin RMC-035 in reducing kidney injury after cardiac surgery: a multicentre, randomised, double-blind, parallel group, phase 2a trial

Jay L. Koyner, Nicolas Noiseux, Alexander Zarbock, Matthias Thielmann et al.
6 citations
EClinicalMedicine
Acute Kidney Injury Research
2.04
article

Efficacy and safety of therapeutic alpha-1-microglobulin RMC-035 in reducing kidney injury after cardiac surgery: a multicentre, randomised, double-blind, parallel group, phase 2a trial

Jay L. Koyner, Nicolas Noiseux, Alexander Zarbock, Matthias Thielmann, C. David Mazer, Benoît de Varennes, Klaus Matschke, Andrej Myjavec, Daniel T. Engelman, Maxime Laflamme, Michael Reusch, J Böhm, Tobias E. Larsson, Andreas Böning, Jan Burkert
article en
6 citations

Abstract

No abstract available for this paper.
EClinicalMedicineVol. 76
St. Michael's Hospital (CA), Baystate Medical Center (US), University of Toronto (CA), Justus-Liebig-Universität Gießen (DE), Charles University (CZ), University of Chicago (US), Royal Victoria Hospital (CA), University Hospital in Motol (CZ), University Hospital Münster (DE), Deutsches Herzzentrum der Charité (DE), Institut universitaire de cardiologie et de pneumologie de Québec (CA), University Hospital Hradec Králové (CZ), Centre Hospitalier de l’Université de Montréal (CA), Deutsches Herzzentrum München (DE), West German Heart and Vascular Center Essen (DE), University of Duisburg-Essen (DE), Technical University of Munich (DE)
University of Toronto
Good health and well-being
Openalex Percentile: Top 11%
Acute Kidney Injury Research
2.04
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Efficacy and safety of therapeutic alpha-1-microglobulin RMC-035 in reducing kidney injury after cardiac surgery: a multicentre, randomised, double-blind, parallel group, phase 2a trial — Jay L. Koyner, Nicolas Noiseux, et al. · EClinicalMedicine (2024) | TGRS Research Map | TGRS